4.5 Article

A proteomic analysis of arsenical drug resistance in Trypanosoma brucei

Journal

PROTEOMICS
Volume 6, Issue 9, Pages 2726-2732

Publisher

WILEY
DOI: 10.1002/pmic.200500419

Keywords

cymelarsan; drug resistance; parasite; proteome; Trypanosoma brucei

Funding

  1. Medical Research Council [G9722968] Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline
  3. Medical Research Council [G9722968] Funding Source: researchfish
  4. MRC [G9722968] Funding Source: UKRI

Ask authors/readers for more resources

We have undertaken 2-DE and MS to identify proteins associated with arsenical drug resistance in Trypanosoma brucei. This parasite causes sleeping sickness in humans, and arsenical drug resistance is a significant potential problem. Comparative analysis of approximately 2000 spots resolved by 2-DE in the soluble proteomes of drug-sensitive and drug-resistant isogenic lines of T. brucei identified a protein spot whose absence associated with resistance to the arsenical drug, Cymelarsan. MS matched this protein to an identical pair of tandem genes Tb09.211.0120 and 0130 that encode a putative nascent polypeptide associated complex subunit. This protein also occurs as an isoform located in both resistant and sensitive lines at a similar molecular weight, but different pi. The difference between isogenic lines was confirmed by Western blot using an antibody against recombinant protein. Both genes were identical in sequence between drug-sensitive and drug-resistant lines and both were transcribed as determined by RT-PCR. We postulate that the missing protein isoform arose due to the lack of a PTM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available